Zainab H. Athab

30 ta ish

Department of Pharmacy, Al-Zahrawi University College, Karbala, Iraq

1. Nanoparticle-Based PCSK9 Inhibition in Viral Infections: Evaluating Clinical Limitations and Advancing Therapeutic Strategies

   Moeen F. Dababneh, Bahjat Alhasso, Abdulkareem Shareef +10

   MaqolaLipoproteins and Cardiovascular HealthJournal of Pharmaceutical Innovation20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.013240

2. Antibody therapies in glioblastoma: Overcoming micro-environmental barriers.

   Moeen F. Dababneh, Faris Anad Muhammad, Abdulkareem Shareef +10

   MaqolaGlioma Diagnosis and TreatmentPubMed20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.015092

3. Ferroptosis in cancer: integrating multi-omics, AI-driven biomarkers, and translational challenges

   ‎Anmar Ghanim Taki, Abdulkareem Shareef, Vimal Arora +10

   MaqolaFerroptosis and cancer prognosisClinica Chimica Acta20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.022814

4. Quercetin as a multi-targeted therapeutic candidate in oral cancers: molecular mechanisms and preclinical evidence

   Qamar Abuhassan, Omer Qutaiba B. Allela, Wadhah Hasan Alkhazali +10

   MaqolaPhytochemicals and Antioxidant ActivitiesMolecular Biology Reports20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.023293

5. Integrin-linked kinase (ILK) in hematologic malignancies: Bridging molecular mechanisms to therapeutic innovation

   Omer Qutaiba B. Allela, Abdulkareem Shareef, Ashishkumar Kyada +9

   MaqolaCell Adhesion Molecules ResearchBioimpacts20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.023956